Pharmaceutical composition comprising inhibitor of neuropilin-1 expression or activity for preventing or treating chronic rhinosinusitis

摘要

The present invention relates to a pharmaceutical composition for the treatment of chronic rhinosinusitis comprising an inhibitor of NRP-1 expression or activity as an active ingredient, and can be usefully used as a treatment or prevention agent for nasal polyps and chronic rhinosinusitis.